Erdogdu, B. Et Al. 2022. Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.32, no.1 , 65-67.

Erdogdu, B., ÇINAR, O. E., Malkan, Ü. Y., AKSU, S., DEMİROĞLU, H., BÜYÜKAŞIK, Y., ... GÖKER, H.(2022). Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.32, no.1, 65-67.

Erdogdu, Batuhan Et Al. "Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.32, no.1, 65-67, 2022

Erdogdu, Batuhan Et Al. "Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.32, no.1, pp.65-67, 2022

Erdogdu, B. Et Al. (2022) . "Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.32, no.1, pp.65-67.

@article{article, author={Batuhan Erdogdu Et Al. }, title={Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2022, pages={65-67} }